|
The global life sciences industry — firms engaged in pharmaceutical, biotechnology, medical device, nutraceuticals, and contract research organizations — operates in a highly regulated environment. Despite a slowing growth rate, the industry remains highly profitable with companies showing strong balance sheets and cash flow.
Marsh's Life Sciences Practice has produced a benchmark study, which compares the risk management and insurance programs of more than 300 buyers of insurance products in the life sciences industry in the United States. This report combines our most current benchmarking data into one single and uniform document focused on the life sciences industry. Benchmarking is an extremely valuable tool that helps us validate insurance-program design, renewal strategies, and pricing targets to achieve positive results for our clients.
Marsh's 2009 Life Sciences Risk Benchmark Report is intended to be a supplemental resource to help our clients make more informed decisions about their insurance programs. The report also outlines some of the recent trends in the global insurance market for life sciences and provides information on all major lines of coverage.
Request a copy of the report.
|
 |
|
|
Request a copy of our Life Sciences Risk Benchmark Report
Life Sciences
Life Sciences Practice Leader
215 246 1030
Life Sciences Practice Knowledge Manager
213 346 5402
Marsh Benchmarking
212 345 1870
|
